CompuGroup Medical SE & Co. KGaA (HAM:COP)
Germany · Delayed Price · Currency is EUR 29.05
-0.35 (-1.19%)
At close: Oct 14, 2026
HAM:COP Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,503 | 1,318 | 1,126 | 1,980 | 1,879 | 3,729 | |
Market Cap Growth | 22.26% | 17.10% | -43.13% | 5.33% | -49.60% | -11.71% |
Enterprise Value | 2,223 | 2,032 | 1,904 | 2,678 | 2,600 | 4,352 |
Last Close Price | 29.05 | 25.01 | 21.31 | 35.82 | 33.67 | 65.91 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 53.80 | 46.67 | 32.54 | 43.12 | 25.60 | 54.07 |
Forward PE | - | 13.77 | - | - | - | - |
PS Ratio | 1.21 | 1.06 | 0.95 | 1.61 | 1.60 | 3.51 |
PB Ratio | 2.34 | 2.05 | 1.74 | 2.96 | 2.79 | 6.09 |
P/FCF Ratio | 11.95 | 10.48 | 10.82 | 12.33 | 15.77 | 26.98 |
P/OCF Ratio | 10.22 | 8.97 | 8.74 | 11.03 | 12.96 | 22.56 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.78 | 1.63 | 1.61 | 2.18 | 2.21 | 4.10 |
EV/EBITDA Ratio | 13.81 | 15.25 | 12.96 | 15.77 | 17.13 | 27.04 |
EV/EBIT Ratio | 25.03 | 23.17 | 19.44 | 21.83 | 26.38 | 40.81 |
EV/FCF Ratio | 17.67 | 16.16 | 18.29 | 16.68 | 21.82 | 31.48 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.25 | 1.25 | 1.36 | 1.15 | 1.17 | 1.21 |
Debt / EBITDA Ratio | 5.02 | 5.02 | 5.13 | 3.96 | 4.43 | 4.06 |
Debt / FCF Ratio | 6.38 | 6.38 | 8.46 | 4.78 | 6.60 | 5.36 |
Net Debt / Equity Ratio | 1.12 | 1.12 | 1.19 | 1.05 | 1.03 | 1.03 |
Net Debt / EBITDA Ratio | 5.40 | 5.40 | 5.26 | 4.14 | 4.59 | 3.94 |
Net Debt / FCF Ratio | 5.72 | 5.72 | 7.42 | 4.38 | 5.84 | 4.59 |
Asset Turnover | 0.65 | 0.65 | 0.61 | 0.64 | 0.63 | 0.63 |
Inventory Turnover | 55.90 | 55.90 | 46.70 | 33.66 | 30.48 | 35.52 |
Quick Ratio | 0.80 | 0.80 | 1.06 | 0.92 | 0.98 | 0.83 |
Current Ratio | 0.94 | 0.94 | 1.19 | 1.07 | 1.12 | 0.93 |
Return on Equity (ROE) | 4.45% | 4.45% | 5.28% | 6.98% | 11.53% | 11.03% |
Return on Assets (ROA) | 2.84% | 2.84% | 3.17% | 3.99% | 3.30% | 3.97% |
Return on Invested Capital (ROIC) | 3.21% | 3.14% | 3.94% | 5.77% | 5.23% | 6.36% |
Return on Capital Employed (ROCE) | 5.90% | 5.90% | 6.00% | 7.90% | 6.30% | 7.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 1.88% | 2.14% | 3.07% | 2.32% | 3.91% | 1.85% |
FCF Yield | 8.37% | 9.54% | 9.25% | 8.11% | 6.34% | 3.71% |
Dividend Yield | 1.72% | 1.96% | 0.23% | 2.64% | 1.39% | 0.70% |
Payout Ratio | 9.16% | 9.16% | 149.52% | 56.88% | 35.58% | 38.23% |
Buyback Yield / Dilution | 1.25% | 1.25% | -0.63% | -0.32% | 1.29% | -1.15% |
Total Shareholder Return | 2.97% | 3.21% | -0.40% | 2.32% | 2.68% | -0.45% |